Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment

Tanta University

Status and phase: Completed; Phase 3; Phase 2

Conditions: COVID-19; Coronavirus Infection

Treatments: Drug: Chloroquine or Hydroxychloroquine

Study type: Interventional

Funder types: Other

Identifiers

NCT04353336

chloroquine covid

Details and patient eligibility

About

Chloroquine or hydroxychloroquine in COVID-19 treatment

Full description

Clinical Study Evaluating the Efficacy of Chloroquine or hydroxychloroquine in COVID-19 treatment

Enrollment: 194 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Covid 19 patients

Exclusion criteria

• Allergy or contraindication to the drug
• Pregnant or lactating
• Patients with cardiac problems

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

194 participants in 2 patient groups

Chloroquine or Hydroxychloroquine

Experimental group

Description:

Chloroquine or Hydroxychloroquine with standard of care treatment.

Treatment:

Drug: Chloroquine or Hydroxychloroquine

No intervention

No Intervention group

Description:

standard of care treatment alone.